Search for: "Momenta, Inc."
Results 41 - 54
of 54
Sort by Relevance
|
Sort by Date
7 Aug 2012, 7:27 am
But the recent split Federal Circuit panel decision in Momenta Pharmaceuticals, Inc. v. [read post]
6 Aug 2012, 8:12 pm
Noonan -- In his dissent from the majority opinion in Momenta Pharmaceuticals, Inc. v. [read post]
6 Aug 2012, 1:00 am
In a decision issued August 3, 2012 in Momenta Pharmaceuticals, Inc. v. [read post]
30 Aug 2011, 5:18 am
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
25 Jul 2011, 1:34 am
Mylan Inc. and Momenta Pharmaceuticals Inc. have each challenged Teva's patents on Copaxone.Separately, note the postGeneric drugs have slower approval route than new ones, backlogged by FDA staff shortage [read post]
10 Jul 2011, 11:29 pm
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
30 Mar 2011, 6:17 am
. * * * [One] of the companies whose stock he allegedly traded was Momenta Pharmaceuticals Inc., a small biotechnology company from Cambridge, Mass., which was vying with two other companies to make a generic version of the blockbuster blood thinner Lovenox. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and… [read post]
3 Nov 2010, 7:00 am
Two years later, Momenta Pharmaceuticals Inc. and its partner Sandoz, part of Novartis AG, filed. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
